Intelligence Β· Patent portfolio
Theravance Biopharma Ireland Patents
Full USPTO pharma patent portfolio for Theravance Biopharma Ireland β grant dates, expiration, and drug cross-links.
- Patents
- 635
- Expiring β€24m
- 58
Quick answer
Theravance Biopharma Ireland has 635 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 58 expire within 24 months β use filters for patent-cliff planning.
-
US 7125892
Aryl aniline Ξ²2 adrenergic receptor agonists
granted -
US 7101909
Calcium channel drugs and uses
granted -
US 7101964
Intermediate for preparing glycopeptide derivatives
granted -
US 7074890
Process for preparing glycopeptide phosphonate derivatives
granted -
US 7074760
Polyacid glycopeptide derivatives
granted -
US 7071224
Diphenylmethyl compounds useful as muscarinic receptor antagonists
granted -
US 7067620
Antibacterial agents
granted -
US 7067482
Cross-linked glycopeptide-cephalosporin antibiotics
granted -
US 7067483
Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin
granted -
US 7067481
Cross-linked glycopeptide-cephalosporin antibiotics
granted -
US 7060712
Crystalline form of aryl aniline Ξ²2 adrenergic receptor agonist
granted -
US 7060703
Indolinone derivatives
granted -
US 7037912
Protein kinase inhibitors
expired -
US 7026288
Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
expired -
US 7015305
Process for preparing glycopeptide derivatives
expired -
US 7015346
Short-acting sedative hypnotic agents for anesthesia and sedation
expired -
US 7015307
Process for purifying glycopeptide phosphonate derivatives
expired -
US 7008923
Glycopeptide phosphonate derivatives
expired -
US 6995138
Cross-linked glycopeptide-cephalosporin antibiotics
expired -
US 6979723
Process for preparing glycopeptide phosphonate derivatives
expired -
US 6974797
Cross-linked glycopeptide-cephalosporin antibiotics
expired -
US 6962970
Glycopeptide derivatives and pharmaceutical compositions containing the same
expired -
US 6949568
Aryl aniline Ξ²2 adrenergic receptor agonists
expired -
US 6949681
Intermediate for preparing glycopeptide derivatives
expired -
US 6916961
Ξ²2-adrenergic receptor agonists
expired -
US 6906031
Polyacid glycopeptide derivatives
expired -
US 6903070
Glycopeptide carboxy-saccharide derivatives
expired -
US 6897305
Calcium channel drugs and uses
expired -
US 6887866
Short-acting sedative hypnotic agents for anesthesia and sedation
expired -
US 6887976
Glycopeptide phosphonate derivatives
expired -
US 6878686
Cross-linked glycopeptide-cephalosporin antibiotics
expired -
US 6872804
Glycopeptide disulfide and thioester derivatives
expired -
US 6872701
Glycopeptide phosphonate derivatives
expired -
US 6872741
Sodium channel modulators
expired -
US 6858584
Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
expired -
US 6831150
Reductive alkylation process
expired -
US 6828299
Polyhydroxy glycopeptide derivatives
expired -
US 6815555
Substituted phenol compounds useful for anesthesia and sedation
expired -
US 6770621
Polyacid glycopeptide derivatives
expired -
US 6756400
Sodium channel modulators
expired -
US 6750241
Protein kinase inhibitors
expired -
US 6747043
Alkoxy aryl &bgr;2 adrenergic receptor agonists
expired -
US 6693202
Muscarinic receptor antagonists
expired -
US 6686362
Indolinone derivatives
expired -
US 6670376
Aryl aniline &bgr;2 adrenergic receptor agonists
expired -
US 6653323
Aryl aniline &bgr;2 adrenergic receptor agonists
expired -
US 6646012
Sodium channel modulators
expired -
US 6635618
Glycopeptide phosphonate derivatives
expired
Frequently asked questions
How many patents does Theravance Biopharma Ireland have?
635 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Theravance Biopharma Ireland patents expire?
58 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory